Research & Innovation 2017
29th – 30th March 2017
Homerton College, Cambridge
Research & Innovation 2017
ELRIG is pleased to invite you to the 5th Annual Research & Innovation Meeting and its new location at Homerton College, in Cambridge, UK on 29th and 30th March, 2017. Building on the success of the meeting in previous years, this year will be a larger, 2-day event that will provide expanded scientific tracks, a larger exhibition and greater networking opportunities with the UK’s most innovative life science companies.
Plenary Keynote Speakers
Investment Committee Chair at Apollo Therapeutics
VP and General Manager at Corning Life Sciences
- Immunotherapy (Oncology- Focus)
- Single cell analysis including transcriptomics, NGS, micro-fluidics
- Immunotherapy (Non-oncology- Focus)
- Physiologically relevant 3D models & scale-up
The meeting will bring together world class speakers and leading academic and industry experts who will discuss the challenges and opportunities for cells as models of disease to improve the success of drug discovery and to develop new therapeutic agents. Hear up-to-date views on this exciting and rapidly evolving area, including presentations on the latest advances and technology breakthroughs.
Each year, Research & Innovation provides a highly impactful learning and networking opportunity for scientists engaged in early-phase drug discovery whether in Academia, Biotech or Pharma. Scientific sessions are complemented by a poster session, networking opportunities and a vendor exhibition with over 40 exhibitors, including recently formed companies with new and disruptive technologies. This meeting will facilitate new ideas and potentiate the cellular models field as it expands into new areas of research and discovery.
Join us for this must-attend event to learn about new state-of-the-art technologies and the latest research and innovation trends in drug discovery!
Click on a link to view interviews with some of the speakers and conference directors at Research & Innovation 2017. With thanks to ELRIG media partners Technology Networks for the following footage:
The challenges of drug discovery
3D cell culture and drug discovery
Moving away from target-based approaches
Using cells as models
The use of tumour spheroids in cancer research
What applications are 3D cultures particularly suited to?
Cancer immunotherapy and the role of Treg depletion
Single cell analysis in diagnostics
Benefits of working on the microscale
Micro sponges for cell culture
Chemoresistance and treating leukemia
The challenges of phenotypic screening
We try to make as many speaker presentations available to download as possible. When we get permission to publish a presentation it will appear in this section.